Wedge Capital Management L L P NC Decreases Stock Holdings in DaVita Inc. (NYSE:DVA)

Wedge Capital Management L L P NC cut its stake in DaVita Inc. (NYSE:DVA) by 6.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 222,007 shares of the company’s stock after selling 16,487 shares during the period. Wedge Capital Management L L P NC’s holdings in DaVita were worth $33,201,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Acadian Asset Management LLC acquired a new position in DaVita during the second quarter worth $212,000. Mercer Global Advisors Inc. ADV raised its stake in shares of DaVita by 18.9% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 9,898 shares of the company’s stock worth $1,455,000 after buying an additional 1,575 shares during the last quarter. Vanguard Personalized Indexing Management LLC boosted its position in shares of DaVita by 30.7% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 4,938 shares of the company’s stock worth $671,000 after buying an additional 1,160 shares in the last quarter. XTX Topco Ltd acquired a new stake in DaVita in the 2nd quarter valued at about $658,000. Finally, Promethos Capital LLC increased its holdings in DaVita by 120.0% during the 2nd quarter. Promethos Capital LLC now owns 28,396 shares of the company’s stock valued at $3,935,000 after acquiring an additional 15,490 shares in the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

DVA has been the subject of a number of recent research reports. Barclays raised their price objective on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Truist Financial raised their price target on DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research report on Monday, October 7th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, DaVita has a consensus rating of “Hold” and a consensus target price of $161.80.

DaVita Stock Up 0.9 %

DVA stock opened at $166.28 on Friday. DaVita Inc. has a one year low of $103.40 and a one year high of $169.51. The stock has a market capitalization of $13.63 billion, a P/E ratio of 17.94, a PEG ratio of 0.75 and a beta of 0.92. The company has a 50 day moving average price of $157.11 and a two-hundred day moving average price of $152.71. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37.

DaVita (NYSE:DVA) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 EPS for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The business had revenue of $3.26 billion during the quarter, compared to analysts’ expectations of $3.25 billion. During the same period in the prior year, the firm earned $2.85 EPS. DaVita’s revenue for the quarter was up 4.6% on a year-over-year basis. As a group, sell-side analysts expect that DaVita Inc. will post 9.71 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.